These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 24532656)

  • 1. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
    Liu X; Zheng N; Shi YN; Yuan J; Li L
    J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis.
    Ha CH; Wang W; Jhun BS; Wong C; Hausser A; Pfizenmaier K; McKinsey TA; Olson EN; Jin ZG
    J Biol Chem; 2008 May; 283(21):14590-9. PubMed ID: 18332134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface.
    Davis FB; Mousa SA; O'Connor L; Mohamed S; Lin HY; Cao HJ; Davis PJ
    Circ Res; 2004 Jun; 94(11):1500-6. PubMed ID: 15117822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzo[a]pyrene inhibits angiogenic factors-induced alphavbeta3 integrin expression, neovasculogenesis, and angiogenesis in human umbilical vein endothelial cells.
    Li CH; Cheng YW; Hsu YT; Hsu YJ; Liao PL; Kang JJ
    Toxicol Sci; 2010 Dec; 118(2):544-53. PubMed ID: 20876236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling.
    Peddibhotla SS; Brinkmann BF; Kummer D; Tuncay H; Nakayama M; Adams RH; Gerke V; Ebnet K
    Mol Biol Cell; 2013 Apr; 24(7):933-44. PubMed ID: 23389628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
    Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
    Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
    Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid Hormone, Hormone Analogs, and Angiogenesis.
    Davis PJ; Sudha T; Lin HY; Mousa SA
    Compr Physiol; 2015 Dec; 6(1):353-62. PubMed ID: 26756636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model.
    Mousa SA; Davis FB; Mohamed S; Davis PJ; Feng X
    Int Angiol; 2006 Dec; 25(4):407-13. PubMed ID: 17164749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin.
    Mousa SA; O'Connor LJ; Bergh JJ; Davis FB; Scanlan TS; Davis PJ
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):356-60. PubMed ID: 16116342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone and angiogenesis.
    Luidens MK; Mousa SA; Davis FB; Lin HY; Davis PJ
    Vascul Pharmacol; 2010; 52(3-4):142-5. PubMed ID: 19879961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production.
    Huang YH; Wu MP; Pan SC; Su WC; Chen YW; Wu LW
    Angiogenesis; 2013 Jan; 16(1):207-22. PubMed ID: 23086340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormones differentially regulate phosphorylation of ERK and Akt via integrin αvβ3 receptor in undifferentiated and differentiated PC-12 cells.
    Barbakadze T; Natsvlishvili N; Mikeladze D
    Cell Biochem Funct; 2014 Apr; 32(3):282-6. PubMed ID: 24214887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
    Davis PJ; Lin HY; Hercbergs A; Mousa SA
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrac as an anti-angiogenic agent in cancer.
    Schmohl KA; Nelson PJ; Spitzweg C
    Endocr Relat Cancer; 2019 Jun; 26(6):R287-R304. PubMed ID: 31063970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
    Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
    Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 Iodothyronine Deiodinase Activity Is Required for Rapid Stimulation of PI3K by Thyroxine in Human Umbilical Vein Endothelial Cells.
    Aoki T; Tsunekawa K; Araki O; Ogiwara T; Nara M; Sumino H; Kimura T; Murakami M
    Endocrinology; 2015 Nov; 156(11):4312-24. PubMed ID: 26284425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PERIOSTIN regulates MMP-2 expression via the αvβ3 integrin/ERK pathway in human periodontal ligament cells.
    Watanabe T; Yasue A; Fujihara S; Tanaka E
    Arch Oral Biol; 2012 Jan; 57(1):52-9. PubMed ID: 21885032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
    Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
    Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.